These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11387492)

  • 1. A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity.
    Lyden PD; Lu M; Levine SR; Brott TG; Broderick J;
    Stroke; 2001 Jun; 32(6):1310-7. PubMed ID: 11387492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity.
    Meyer BC; Hemmen TM; Jackson CM; Lyden PD
    Stroke; 2002 May; 33(5):1261-6. PubMed ID: 11988601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified National Institutes of Health Stroke Scale can be estimated from medical records.
    Kasner SE; Cucchiara BL; McGarvey ML; Luciano JM; Liebeskind DS; Chalela JA
    Stroke; 2003 Feb; 34(2):568-70. PubMed ID: 12574577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modified National Institutes of Health Stroke Scale: its time has come.
    Meyer BC; Lyden PD
    Int J Stroke; 2009 Aug; 4(4):267-73. PubMed ID: 19689755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators.
    Lyden P; Lu M; Jackson C; Marler J; Kothari R; Brott T; Zivin J
    Stroke; 1999 Nov; 30(11):2347-54. PubMed ID: 10548669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial.
    Broderick JP; Lu M; Kothari R; Levine SR; Lyden PD; Haley EC; Brott TG; Grotta J; Tilley BC; Marler JR; Frankel M
    Stroke; 2000 Oct; 31(10):2335-41. PubMed ID: 11022060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of minor stroke definitions for thrombolysis decision making.
    Park TH; Hong KS; Choi JC; Song P; Lee JS; Lee J; Park JM; Kang K; Lee KB; Cho YJ; Saposnik G; Han MK; Bae HJ
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):482-90. PubMed ID: 23545318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and Reliability of the Persian Versions of National Institute of Health Stroke Scale and Modified National Institute of Health Stroke Scale in Hospitalized Patients.
    Dehghani R; Borhanihaghighi A; Shariat A; Nami M; Nazeri M; Abolhasani Foroughi A; Mehrabi S; Emamghoreishi M
    Galen Med J; 2019; 8():e1188. PubMed ID: 34466470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
    Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke.
    Brown DL; Johnston KC; Wagner DP; Haley EC
    Stroke; 2004 Jan; 35(1):147-50. PubMed ID: 14657446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials.
    Khatri P; Kleindorfer DO; Yeatts SD; Saver JL; Levine SR; Lyden PD; Moomaw CJ; Palesch YY; Jauch EC; Broderick JP
    Stroke; 2010 Nov; 41(11):2581-6. PubMed ID: 20814000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health Stroke Scale certification is reliable across multiple venues.
    Lyden P; Raman R; Liu L; Emr M; Warren M; Marler J
    Stroke; 2009 Jul; 40(7):2507-11. PubMed ID: 19520998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials.
    Saver JL; Yafeh B
    Stroke; 2007 Feb; 38(2):414-6. PubMed ID: 17234987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
    Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I.
    Hacke W; Bluhmki E; Steiner T; Tatlisumak T; Mahagne MH; Sacchetti ML; Meier D
    Stroke; 1998 Oct; 29(10):2073-5. PubMed ID: 9756584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-day NIHSS is a sensitive outcome measure for exploratory clinical trials in acute stroke: evidence from the Virtual International Stroke Trials Archive.
    Kerr DM; Fulton RL; Lees KR;
    Stroke; 2012 May; 43(5):1401-3. PubMed ID: 22308254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex.
    Mandava P; Murthy SB; Munoz M; McGuire D; Simon RP; Alexandrov AV; Albright KC; Boehme AK; Martin-Schild S; Martini S; Kent TA
    Stroke; 2013 Jun; 44(6):1525-31. PubMed ID: 23674524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
    Clark WM; Albers GW; Madden KP; Hamilton S
    Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abbreviation of the Follow-Up NIH Stroke Scale Using Factor Analysis.
    Raza SA; Frankel MR; Rangaraju S
    Cerebrovasc Dis Extra; 2017; 7(3):120-129. PubMed ID: 28968607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial.
    Grotta JC; Welch KM; Fagan SC; Lu M; Frankel MR; Brott T; Levine SR; Lyden PD
    Stroke; 2001 Mar; 32(3):661-8. PubMed ID: 11239184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.